K. Nam
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Co-authors
- Yves Fradet (3 shared papers)Dean F. Bajorin (6 shared papers)Ronald de Wit (6 shared papers)Tara L. Frenkl (5 shared papers)Andrea Necchi (3 shared papers)Howard Gurney (2 shared papers)David J. Vaughn (2 shared papers)Lawrence Fong (2 shared papers)
- Journals
- Annals of Oncology (7 papers)European Urology Supplements (1 paper)European Urology Open Science (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
K. Nam
9 papers receiving 397 citations
K. Nam's Hit Papers
Peers
Comparison fields: 5 of 26
- Oncology 201
- Surgery 272
- Pulmonary and Respiratory Medicine 64
- Urology 10
- Cancer Research 17
Countries citing papers authored by K. Nam
This map shows the geographic impact of K. Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Nam more than expected).
Fields of papers citing papers by K. Nam
This network shows the impact of papers produced by K. Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Nam. The network helps show where K. Nam may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Nam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up Hit paper breakdown → | 2019 | 322 |
| 2 | 2020 | 49 | |
| 3 | 2018 | 11 | |
| 4 | 2019 | 10 | |
| 5 | 2016 | 2 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2019 | 1 |
About K. Nam
K. Nam is a scholar working on Surgery, Oncology, Molecular Biology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 399 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Advanced Breast Cancer Therapies (1 paper), Urinary and Genital Oncology Studies (1 paper), Gut microbiota and health (1 paper) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Oncology (201 citations), Surgery (272 citations), Pulmonary and Respiratory Medicine (64 citations), Urology (10 citations) and Cancer Research (17 citations). K. Nam has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Yves Fradet, Dean F. Bajorin, Ronald de Wit, Tara L. Frenkl, Andrea Necchi, Howard Gurney, David J. Vaughn, Lawrence Fong, Daniel P. Petrylak and Joaquim Bellmunt. Their work appears in journals such as Annals of Oncology, European Urology Supplements and European Urology Open Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.